According to WiseGuy Reports, the Myristoyl Pentapeptide 17 Market was valued at USD 300 million in 2024 and reached USD 300 million in 2025. The market is projected to grow to USD 500 million by 2035, expanding at a CAGR of 5.9% during the forecast period. Increasing demand for anti-aging skincare products, growing cosmetic industry applications, rising adoption of peptide-based formulations, expansion of online beauty retail channels, and continuous innovation in personal care products are driving market growth. Major companies including Innospec, Dow Chemical, Mibelle Group, Ashland, Sederma, Lonza Group, Croda International, Evonik Industries, BASF, and Givaudan are focusing on advanced ingredient development and strategic expansion to strengthen their market positions.

Market Overview

Myristoyl Pentapeptide 17 is a specialized peptide ingredient widely used in cosmetic and personal care formulations due to its skin-enhancing and hair care properties. The ingredient has gained attention for its application in anti-aging products, skincare serums, creams, lotions, and advanced cosmetic formulations.

The increasing preference for high-performance beauty products has encouraged cosmetic manufacturers to incorporate peptide-based ingredients into their product portfolios. Consumers are increasingly seeking solutions that support skin health, improve appearance, and provide targeted benefits through scientifically developed formulations.

Growing innovation in cosmetic ingredients and increasing investments in research and development activities are contributing to the expansion of the Myristoyl Pentapeptide 17 industry.

Market Size Reached in 2025

The Myristoyl Pentapeptide 17 Market reached USD 300 million in 2025, supported by rising demand from skincare and beauty product manufacturers. The growing popularity of premium anti-aging products has created strong opportunities for suppliers of advanced peptide ingredients.

Cosmetic brands are increasingly introducing products containing active ingredients that provide visible benefits, encouraging the adoption of specialized peptides in serums, creams, and other formulations.

The expansion of online beauty platforms has further improved accessibility to peptide-based skincare products, enabling manufacturers to reach a wider consumer base across global markets.

Expected Market Size by 2035

The market is expected to reach USD 500 million by 2035 as demand for innovative cosmetic formulations continues increasing. Growth in anti-aging product categories, rising consumer awareness regarding skincare ingredients, and expanding applications in hair care are expected to support long-term market development.

Increasing investment in biotechnology and cosmetic research is also expected to create opportunities for the development of improved peptide formulations with enhanced performance characteristics.

Market CAGR

The projected CAGR of 5.9% reflects steady growth driven by increasing adoption of advanced skincare ingredients and expanding applications across cosmetic industries. Manufacturers are focusing on improving formulation efficiency while developing products that meet changing consumer expectations.

Continuous advancements in peptide technology and growing demand for multifunctional beauty ingredients are expected to maintain positive market momentum during the forecast period.

Key Growth Drivers

The growing demand for anti-aging products is one of the primary factors supporting market expansion. Consumers are increasingly investing in skincare products designed to address signs of aging, creating opportunities for manufacturers using advanced peptide ingredients.

The expansion of the global cosmetics industry is another important growth driver. Beauty brands are continuously introducing innovative formulations containing active ingredients to differentiate their products in a competitive market.

Rising adoption of hair care products containing peptide-based ingredients is also contributing to demand growth. Manufacturers are exploring new applications of Myristoyl Pentapeptide 17 in products designed to support healthier hair appearance and performance.

The rapid growth of e-commerce platforms has improved distribution opportunities for cosmetic products, allowing consumers to access specialized skincare solutions more easily.

Emerging Market Trends

The shift toward science-based skincare formulations is becoming a significant trend in the cosmetic industry. Consumers are increasingly interested in products supported by advanced research and active ingredients with targeted benefits.

Personalized skincare solutions are also gaining popularity as brands develop products designed for specific consumer needs. This trend is encouraging greater innovation in peptide-based formulations.

Sustainable beauty practices are influencing ingredient development as manufacturers explore environmentally responsible production methods and cleaner formulation approaches.

Advanced delivery technologies are being introduced to improve the effectiveness of cosmetic ingredients and enhance consumer experiences.

Competitive Landscape

The Myristoyl Pentapeptide 17 Market features strong competition among global ingredient manufacturers and cosmetic solution providers. Companies are focusing on research and development, product innovation, and strategic collaborations to expand their market presence.

Key market participants include Innospec, Dow Chemical, Mibelle Group, Happi, Ashland, Sederma, AkzoNobel, SABIC, Lonza Group, Sytheon, Rudolf GmbH, Croda International, Evonik Industries, BASF, and Givaudan.

These companies are investing in advanced peptide technologies, expanding ingredient portfolios, and developing innovative solutions for skincare, dermatology, and hair care applications.

The Myristoyl Pentapeptide 17 Market is expected to maintain steady growth through 2035 as demand for premium cosmetic products, advanced anti-aging solutions, and innovative peptide formulations continues to expand worldwide.